Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers

Jacob McGee, Joanne Kotsopoulos, Jan Lubinski, Henry T. Lynch, Barry Rosen, Nadine Tung, Charmaine Kim-Sing, Beth Karlan, William D. Foulkes, Peter Ainsworth, Parviz Ghadirian, Leigha Senter, Andrea Eisen, Ping Sun, Steven A. Narod

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Studies conducted among women in the general population suggest that various anthropometric measures, including height and weight, may be associated with the risk of developing ovarian cancer. Whether such an association exists among women who carry a BRCA1 or BRCA2 mutation has not been evaluated. Thus, we investigated the association between height, weight, changes in body weight, and BMI, and the risk of developing ovarian cancer among 938 women carrying a BRCA1 or BRCA2 mutation. A matched case-control study was conducted in 469 pairs of women carrying a deleterious mutation in either BRCA1 (n = 403 pairs) or BRCA2 (n = 66 pairs). Information about height and weight at ages 18, 30, and 40 was collected from a questionnaire routinely administered to women during the course of genetic counseling. Conditional logistic regression was used to estimate the association between these body size measures and the risk of ovarian cancer. Height, weight, and BMI were not associated with the risk of ovarian cancer (P-trend >0.15). Also, there was no association between changes in body weight between ages 18-30, or ages 30-40, or ages 18-40 and the risk of ovarian cancer (P-trend 0.28). The results from this study suggest that height, weight, or weight gain do not influence the risk of ovarian cancer among carriers of a BRCA1 or BRCA2 mutation.

Original languageEnglish
Pages (from-to)1288-1292
Number of pages5
JournalObesity
Volume20
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Ovarian Neoplasms
Mutation
Body Weight Changes
Weights and Measures
Body Weights and Measures
Genetic Counseling
Body Size
Weight Gain
Case-Control Studies
Logistic Models
Population

All Science Journal Classification (ASJC) codes

  • Endocrinology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

McGee, J., Kotsopoulos, J., Lubinski, J., Lynch, H. T., Rosen, B., Tung, N., ... Narod, S. A. (2012). Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. Obesity, 20(6), 1288-1292. https://doi.org/10.1038/oby.2011.394

Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. / McGee, Jacob; Kotsopoulos, Joanne; Lubinski, Jan; Lynch, Henry T.; Rosen, Barry; Tung, Nadine; Kim-Sing, Charmaine; Karlan, Beth; Foulkes, William D.; Ainsworth, Peter; Ghadirian, Parviz; Senter, Leigha; Eisen, Andrea; Sun, Ping; Narod, Steven A.

In: Obesity, Vol. 20, No. 6, 06.2012, p. 1288-1292.

Research output: Contribution to journalArticle

McGee, J, Kotsopoulos, J, Lubinski, J, Lynch, HT, Rosen, B, Tung, N, Kim-Sing, C, Karlan, B, Foulkes, WD, Ainsworth, P, Ghadirian, P, Senter, L, Eisen, A, Sun, P & Narod, SA 2012, 'Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers', Obesity, vol. 20, no. 6, pp. 1288-1292. https://doi.org/10.1038/oby.2011.394
McGee, Jacob ; Kotsopoulos, Joanne ; Lubinski, Jan ; Lynch, Henry T. ; Rosen, Barry ; Tung, Nadine ; Kim-Sing, Charmaine ; Karlan, Beth ; Foulkes, William D. ; Ainsworth, Peter ; Ghadirian, Parviz ; Senter, Leigha ; Eisen, Andrea ; Sun, Ping ; Narod, Steven A. / Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. In: Obesity. 2012 ; Vol. 20, No. 6. pp. 1288-1292.
@article{9d760bf03f02412e916e6f79b670edb4,
title = "Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers",
abstract = "Studies conducted among women in the general population suggest that various anthropometric measures, including height and weight, may be associated with the risk of developing ovarian cancer. Whether such an association exists among women who carry a BRCA1 or BRCA2 mutation has not been evaluated. Thus, we investigated the association between height, weight, changes in body weight, and BMI, and the risk of developing ovarian cancer among 938 women carrying a BRCA1 or BRCA2 mutation. A matched case-control study was conducted in 469 pairs of women carrying a deleterious mutation in either BRCA1 (n = 403 pairs) or BRCA2 (n = 66 pairs). Information about height and weight at ages 18, 30, and 40 was collected from a questionnaire routinely administered to women during the course of genetic counseling. Conditional logistic regression was used to estimate the association between these body size measures and the risk of ovarian cancer. Height, weight, and BMI were not associated with the risk of ovarian cancer (P-trend >0.15). Also, there was no association between changes in body weight between ages 18-30, or ages 30-40, or ages 18-40 and the risk of ovarian cancer (P-trend 0.28). The results from this study suggest that height, weight, or weight gain do not influence the risk of ovarian cancer among carriers of a BRCA1 or BRCA2 mutation.",
author = "Jacob McGee and Joanne Kotsopoulos and Jan Lubinski and Lynch, {Henry T.} and Barry Rosen and Nadine Tung and Charmaine Kim-Sing and Beth Karlan and Foulkes, {William D.} and Peter Ainsworth and Parviz Ghadirian and Leigha Senter and Andrea Eisen and Ping Sun and Narod, {Steven A.}",
year = "2012",
month = "6",
doi = "10.1038/oby.2011.394",
language = "English",
volume = "20",
pages = "1288--1292",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers

AU - McGee, Jacob

AU - Kotsopoulos, Joanne

AU - Lubinski, Jan

AU - Lynch, Henry T.

AU - Rosen, Barry

AU - Tung, Nadine

AU - Kim-Sing, Charmaine

AU - Karlan, Beth

AU - Foulkes, William D.

AU - Ainsworth, Peter

AU - Ghadirian, Parviz

AU - Senter, Leigha

AU - Eisen, Andrea

AU - Sun, Ping

AU - Narod, Steven A.

PY - 2012/6

Y1 - 2012/6

N2 - Studies conducted among women in the general population suggest that various anthropometric measures, including height and weight, may be associated with the risk of developing ovarian cancer. Whether such an association exists among women who carry a BRCA1 or BRCA2 mutation has not been evaluated. Thus, we investigated the association between height, weight, changes in body weight, and BMI, and the risk of developing ovarian cancer among 938 women carrying a BRCA1 or BRCA2 mutation. A matched case-control study was conducted in 469 pairs of women carrying a deleterious mutation in either BRCA1 (n = 403 pairs) or BRCA2 (n = 66 pairs). Information about height and weight at ages 18, 30, and 40 was collected from a questionnaire routinely administered to women during the course of genetic counseling. Conditional logistic regression was used to estimate the association between these body size measures and the risk of ovarian cancer. Height, weight, and BMI were not associated with the risk of ovarian cancer (P-trend >0.15). Also, there was no association between changes in body weight between ages 18-30, or ages 30-40, or ages 18-40 and the risk of ovarian cancer (P-trend 0.28). The results from this study suggest that height, weight, or weight gain do not influence the risk of ovarian cancer among carriers of a BRCA1 or BRCA2 mutation.

AB - Studies conducted among women in the general population suggest that various anthropometric measures, including height and weight, may be associated with the risk of developing ovarian cancer. Whether such an association exists among women who carry a BRCA1 or BRCA2 mutation has not been evaluated. Thus, we investigated the association between height, weight, changes in body weight, and BMI, and the risk of developing ovarian cancer among 938 women carrying a BRCA1 or BRCA2 mutation. A matched case-control study was conducted in 469 pairs of women carrying a deleterious mutation in either BRCA1 (n = 403 pairs) or BRCA2 (n = 66 pairs). Information about height and weight at ages 18, 30, and 40 was collected from a questionnaire routinely administered to women during the course of genetic counseling. Conditional logistic regression was used to estimate the association between these body size measures and the risk of ovarian cancer. Height, weight, and BMI were not associated with the risk of ovarian cancer (P-trend >0.15). Also, there was no association between changes in body weight between ages 18-30, or ages 30-40, or ages 18-40 and the risk of ovarian cancer (P-trend 0.28). The results from this study suggest that height, weight, or weight gain do not influence the risk of ovarian cancer among carriers of a BRCA1 or BRCA2 mutation.

UR - http://www.scopus.com/inward/record.url?scp=84861573138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861573138&partnerID=8YFLogxK

U2 - 10.1038/oby.2011.394

DO - 10.1038/oby.2011.394

M3 - Article

VL - 20

SP - 1288

EP - 1292

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 6

ER -